La porpora trombocitopenica idiopatica: una stima del costo della malattia in Italia

Introduction Immune thrombocytopenic purpura (ITP), a rare autoimmune disorder characterized by formation of anti-platelet antibodies, causes an increased medical resource utilization associated with bleeding events, hospitalization, emergency medication. This study aimed at assessing the current clinical practice and resources used in the treatment of ITP in Italy, and at estimating the total cost of ITP-related care.